Singapore, 29 December 2022 — Aevice Health, a Singapore-based MedTech company developing novel wearables for remote respiratory monitoring, today announced that it will introduce its flagship medical device, the AeviceMD, at CES 2023, Jan. 5 – 8,2023. The AeviceMD has received the CES® 2023 Best of Innovation Awards in the digital health category, an award recognising the best of breakthrough technologies improving health equity and saving lives.

Weighing barely 0.31 ounces and measuring 1.2 inches in diameter, the AeviceMD is the world’s smallest smart wearable stethoscope. The coin-sized sensor enables round-the-clock care at home by listening and analyzing the patient’s heart and lung sounds continuously. When its algorithm detects abnormalities ahead, it notifies caregivers to take early actions, arresting exacerbations before they escalate.

Worn on the patient’s chest using a proprietary silicone patch that is soft, flexible and repositionable, the AeviceMD is uniquely designed to prioritize comfort and wearability for a wide population from pediatrics to geriatrics while reducing wastage caused by single-used adhesives.

“It is an honor for our AeviceMD to be accorded the prestigious CES Best of Innovation award. Growing up with asthma, it’s heartwarming to see how our technology usher new ways chronic respiratory disease can be managed beyond the hospital by monitoring key symptoms that are previously only recognizable by healthcare professionals in-person.” Adrian Ang, CEO of Aevice Health said. “This award is a testament to the hard work and support we’ve received over the years and a large motivation for us to remain steadfast in our goal of delivering effective, affordable, and comfortable care for patients.”

This year’s CES Innovation Awards program received a record high number of over 2100 submissions. The CES Innovation Awards program, owned and produced by the Consumer Technology Association (CTA)®, is an annual competition honoring outstanding design and engineering in 28 consumer technology product categories. Those with the highest rating receive the “Best of Innovation” distinction. An elite panel of industry expert judges, including members of the media, designers, engineers and more, reviewed submissions based on innovation, engineering and functionality, aesthetic and design.

The Aevice Health booth will be located in Tech West, Hall G, Booth 60849. The AeviceMD will also be showcased at the Innovation Awards display, located in the Venetian Expo, Hall D #56320.

About Aevice Health
‍
‍Aevice Health Pte Ltd is a Singapore-based MedTech company at the forefront of addressing chronic respiratory disease, one of the generation’s biggest healthcare challenges. The company’s non-invasive wearable devices enable the early detection of cardiopulmonary abnormalities remotely and in real-time, so that patients can receive fast and targeted care from the ease of their homes. Clinicians can also gain insights into their patients’ health and track their responses to treatment plans easily from the Aevice analytical platform. In Aevice Health, our mission is to drive medical innovations that transform healthcare, improve outcomes and empower lives.
‍
More information about the company can be found at www.aevice.com.


For media enquiries, please contact:

Janelle Low
Aevice Health Pte Ltd
janellelow@aevice.com